177 related articles for article (PubMed ID: 27466381)
21. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas.
Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S
Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D
Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.
Ito R; Oue N; Yoshida K; Kunimitsu K; Nakayama H; Nakachi K; Yasui W
Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349
[TBL] [Abstract][Full Text] [Related]
24. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
25. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
26. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
27. Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.
Suh JH; Won KY; Kim GY; Bae GE; Lim SJ; Sung JY; Park YK; Kim YW; Lee J
Int J Clin Exp Pathol; 2015; 8(11):14608-18. PubMed ID: 26823784
[TBL] [Abstract][Full Text] [Related]
28. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
29. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
31. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
[TBL] [Abstract][Full Text] [Related]
32. [Expression of HER-2 and leptin in gastric cancer and their clinical significance].
Geng YT; Qiu JR; Wang R; Su YT; Shu YQ; Yin YM
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):764-9. PubMed ID: 22335909
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
34. ATAD2 is overexpressed in gastric cancer and serves as an independent poor prognostic biomarker.
Zhang M; Zhang C; Du W; Yang X; Chen Z
Clin Transl Oncol; 2016 Aug; 18(8):776-81. PubMed ID: 26527032
[TBL] [Abstract][Full Text] [Related]
35. Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance.
Ayed-Guerfali DB; Hassairi B; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2014 Mar; 35(3):1775-83. PubMed ID: 24197976
[TBL] [Abstract][Full Text] [Related]
36. Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.
Walch A; Seidl S; Hermannstädter C; Rauser S; Deplazes J; Langer R; von Weyhern CH; Sarbia M; Busch R; Feith M; Gillen S; Höfler H; Luber B
Mod Pathol; 2008 May; 21(5):544-52. PubMed ID: 18246045
[TBL] [Abstract][Full Text] [Related]
37. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer.
Yonemura Y; Ninomiya I; Kaji M; Sugiyama K; Fujimura T; Tsuchihara K; Kawamura T; Miyazaki I; Endou Y; Tanaka M
Anal Cell Pathol; 1995 Mar; 8(2):177-90. PubMed ID: 7786814
[TBL] [Abstract][Full Text] [Related]
38. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.
Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX
World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362
[TBL] [Abstract][Full Text] [Related]
39. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]